Long-term survival after multimodal therapy for advanced hepatocellular carcinoma: a case report
Hepatocellular carcinoma (HCC) complicated by portal vein tumor thrombosis (PVTT) is associated with limited therapeutic options and poor survival. Immune checkpoint inhibitors, especially when combined with tyrosine kinase inhibitors (TKIs), locoregio…